For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
|
| Basic information |
| Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
| Tai Kuo Kuang |
Chang Hung Ming |
LIN PEI I |
02-23519800 |
5F.-1, No.5, Shaoxing N.St., Zhongzheng Dist.Taipei City 10049, Taiwan (R.O.C.) |
2019/09/25 |
| Industrycategory |
Key businesses |
| Biotechnology and Medical Care |
Feng Chi Biotech Corp was founded in 1992, and started for distributing international biomedical products. We represent more than 20 world leading brands, and our sales channel penetrates to clinical and academic institute, food industry, bioproduction industry, and pharmaceutical industry.
We established clinical molecular laboratory to provide genetic testing and assay development using MassARRAY, and next generation sequencing technology. Our laboratory is recognized as Agena Certificated Service Provider, and ISO17025 accredited by Taiwan Accreditation Foundation(TAF).
As a regional distributor, Feng Chi Biotech Corp offers customer-oriented pre-sales and after-sales service, and organizes marketing activity like exhibition, symposium, training program, and internet marketing to consolidate customer relationship. We are not only being a distributor, but also establishing research and development resource to create additional value for all our product portfolio. |
| Financial data |
| Cash flows statement
| Item
|
|
|
| Amount(NTD, in thousands) |
| Cash flows from operating activities |
|
|
| Cash flows from investing activities |
|
|
| Cash flows from financing activities |
|
|
Consolidated/Individual
balance sheet
|
Current assets |
|
|
| Non-current assets |
|
|
| Total assets |
|
|
| Current liabilities |
|
|
| Non-current liabilities |
|
|
| Total liabilities |
|
|
| Share capital |
|
|
| Capital surplus |
|
|
| Retained earnings |
|
|
| Other equity interest |
|
|
| Treasury shares |
|
|
| Total equity attributable to owners of parent |
|
|
| Non-controlling interests |
|
|
| Total equity |
|
|
| Book Value per share(NT$) |
|
|
Consolidated/Individual
profit and loss
statement |
Operating revenue |
|
|
| Operating costs |
|
|
| Gross profit from operations |
|
|
| Operating expenses |
|
|
| Net other income (expenses) |
|
|
| Net operating income |
|
|
| Non-operating income and expenses |
|
|
| Profit before tax |
|
|
| Tax expense |
|
|
| Profit from continuing operations |
|
|
| Profit from discontinued operations |
|
|
| Profit |
|
|
| Other comprehensive income |
|
|
| Comprehensive income |
|
|
| Basic earnings per share |
|
|
 Auditor's report on latest financial statements： auditor's report：
|
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|
